IM Cannabis Corp. (IMCC) Q2 2024 Earnings Call Transcript Summary
IM Cannabis Corp. (IMCC) Q2 2024 Earnings Call Transcript Summary
Operating expenses decreased by 29% due to reductions in G&A and sales & marketing expenditures.The following is a summary of the IM Cannabis Corp. (IMCC) Q2 2024 Earnings Call Transcript:
以下是Im Cannabis Corp. (IMCC) Q2 2024業績會議通話記錄摘要：
Financial Performance:
金融業績：
Reported Q2 2024 revenue increased by 11.7% year over year, amounting to $14.8 million, primarily due to the strong performance in the German market.
Gross profit for Q2 2024 was $0.8 million, a decrease of 75.6% year over year, adversely impacted by clearing old inventory and accruals for slow-moving stock totaling approximately $1.9 million.
Operating expenses decreased by 29% due to reductions in G&A and sales & marketing expenditures.
Non-IFRS adjusted EBITDA loss in Q2 2024 was $2.3 million, a substantial increase from a loss of $0.5 million in Q2 2023.
Net loss slightly improved to $3.5 million in Q2 2024 from $3.7 million in Q2 2023.
報告顯示，Q2 2024年營業收入同比增長11.7％，達到1480萬美元，主要由於德國市場表現強勁。
Q2 2024年毛利潤爲80萬美元，同比下降75.6％，受舊庫存清貨和緩慢進貨而影響，合計約190萬美元。
由於總務及銷售市場支出減少，營業費用下降了29％。
Q2 2024年非IFRS調整後的EBITDA虧損爲230萬美元，較Q2 2023年的虧損500000美元大幅增加。
Q2 2024年淨虧損略有改善，從Q2 2023年的370萬美元降至350萬美元。
Business Progress:
業務進展：
Focused on the German market post-cannabis legalization, resulting in Q2 sales climbing 200% compared to Q1.
Enhanced sales efforts in Germany led by establishing a supply chain from Israel to Germany and concentrating on reliably supplying mid-market to premium cannabis products.
Strengthened the premium product line in the Israeli market by launching and rebranding under BLKMKT, PICO, and IMC Craft brands.
在大麻合法化後，重點關注德國市場，導致Q2銷售額較Q1增長了200％。
通過建立以色列到德國的供應鏈並專注於可靠地供應中檔到高檔的大麻產品，增強了在德國的銷售力度。
通過推出和重新推廣BLKMKt，PICO和IMC Craft品牌，加強了以色列市場的高檔產品線。
Opportunities:
機會：
The legalization of cannabis in Germany and subsequent market growth provide significant expansion opportunities, with expected growth from a $1.5 billion industry in 2024 to $3.7 billion by 2027.
Targeting an increase in the supply of premium and ultra-premium products in both the Israeli and German markets.
德國大麻的合法化和隨後的市場增長提供了重要的擴張機會，預計2024年1500萬美元的行業板塊在2027年將增長到3700萬美元。
在以色列和德國市場都力求增加高檔和超高檔產品的供應。
Risks:
風險：
Continued clearing of old inventory and accruing for slow-moving stock impacting the gross margin.
Reallocation of company resources prioritizing the German market poses potential risks if the expected returns are not met.
繼續清理舊庫存和計提緩慢進貨的股票會影響毛利率。
公司資源的重新分配將優先考慮德國市場，如果預期的回報未達到，可能會帶來潛在的風險。
Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：本文由AI生成。文章內容的準確性無法完全保證。有關更全面的詳細信息，請參閱IR網站。本文只是爲投資者提供參考，沒有任何指導或推薦建議。